Megan Daly, M.D.
Clinical Interests
Dr. Daly has a clinical focus on the treatment of thoracic malignancies, lymphoma, and head and
neck cancers. She specializes in a variety of radiotherapy techniques including stereotactic body
radiotherapy (SBRT), intensity modulated radiation therapy (IMRT), and image guided radiation
therapy (IGRT).
Research Interests
Dr. Daly’s research interests focus on the use of stereotactic body radiotherapy for the treatment of
early-stage lung cancer, metastatic lesions to the lung, and for primary and metastatic tumors of the
spine. She also has a research interest in head and neck cancer, specifically in the use of advances
in image guidance and conformal treatments to allow dose escalation while sparing normal tissues
and reducing the side-effect profile of radiation treatment.
Philosophy of Care
I believe in treating cancer aggressively while maintaining my patients’ quality of life and wellbeing. I feel that cancer treatment is a partnership between each patient and the team of specialists
providing care. My goal is for my patients to fully understand all treatment options and to feel
completely comfortable with their treatment decisions.
Title
Specialty
Assistant Professor
Cancer, Radiation Oncology
Department
Radiation Oncology
Division
Radiation Oncology
Clinic
Center/Program Affiliation
Address/Phone
UC Davis Cancer Center
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center, 4501 X St. Sacramento, CA 95817
Phone: 800-362-5566
Additional Phone
Education
Physician Referrals: 800-362-5566
M.D., Stanford University, Stanford, California, 2006
B.S., Stanford University, Stanford, California, 2001
Megan Daly, M.D.
Internships
Santa Clara Valley Medical Center, San Jose, CA, 2007
Residency
Stanford University, Stanford, CA, 2011
Board Certifications
Professional Memberships
Medical Board of California-Physician and Surgeon license, 2007
American Society for Clinical Oncology (ASCO)
American Society for Therapeutic Radiology and Oncology (ASTRO)
International Association for the Study of Lung Cancer (IASLC)
Honors and Awards
RNSA Roentgen Resident/Fellow Research Award, 2011
AAWR Member-in-Training Award for Outstanding ASTRO Presentation, 2009
Arnold P. Gold Foundation Humanism and Excellence in Teaching Award-Stanford Medical
School, 2009
Stanford Medical Scholars grant recipient, 2003
Fight for Sight Research Fellow, 1999
National Merit Scholar, 1997
Select Recent Publications
Daly ME*, Luxton G*, Choi CYH, Gibbs IC, Chang SD, Adler JR, Soltys SG. Normal tissue
complication probability estimation by the Lyman-Kutcher-Berman method does not accurately
predict spinal cord tolerance to stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2011 April
29. [Epub ahead of print]
Daly ME, Choi CYH, Gibbs IC, Lieberson RE, Adler JA, Chang SD, Soltys SG. Tolerance of the
spinal cord to stereotactic radiosurgery: Insights from hemangioblastomas. Int J Radiat Oncol Biol
Phys 2011 May1; 80(1):213-220.
Daly ME, Le QT, Jain A, Maxim PG, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Colevas AD, Pinto
HA, Chang DT. Intensity modulated radiotherapy for locally advanced cancers of the hypopharynx
and larynx. Head Neck 2011 Jan; 33(1): 103-11. [Epub ahead of print]
Daly ME, Le QT, Kozak M, Maxim PG, Murphy JD, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ,
Chang DT. Intensity modulated radiotherapy for oral cavity squamous cell carcinoma: Patterns of
failure and predictors of local control. Int J Radiat Oncol Biol Phys 2011 Aug 1; 80(5):1912-22.
[Epub ahead of print]
Daly ME, Murphy JD, Mok E, Christman-Skiller C, Koong AC, Chang DT. Rectal and bladder
deformation and displacement during pre-operative radiotherapy for rectal cancer: Are current
contouring guidelines adequate for conformal therapy? Practical Radiation Oncology 2011 AprilJune; 1(2): 85-94.
Megan Daly, M.D.
Murphy JD, Chang DT, Abelson J, Daly ME, Yeung HN, Nelson LM, Koong AC. Cost effectiveness
of radiotherapy in locally advanced pancreatic cancer. Cancer 2011 July 19 [Epub ahead of print]
Murphy JD, Chisholm KM, Daly ME, Wiegner EA, Truong D, Iagaru A, Maxim PG, Loo BW,
Graves EE, Kaplan MJ, Kong C, Le QT. Correlation between metabolic tumor volume and
pathologic tumor volume in head and neck cancer. Radiother Oncol. 2011 Dec; 101(3): 356-61.
[Epub ahead of print]
Daly ME, Le QT, Maxim PG, Loo BW, Kaplan MK, Fischbein NJ, Pinto H, Chang DT. Intensitymodulated radiotherapy for oropharyngeal carcinoma: Clinical outcomes and patterns of failure.
Int J Radiat Oncol Biol Phys 2010 Apr; 76(5):1339-46.
Daly ME and Horst KC. Locoregional management of breast cancer in women under 40. Breast
Diseases: A Year Book Quarterly. 2010 Aug; 21(3):207-10.
Chen AM, Daly ME, El-Sayad I, Garcia J, Lee NY, Bucci MK, Kaplan MJ. Patterns of failure after
combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated
carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2008 Feb 1; 70(2):338-343.
Daly ME, Chen AM, Bucci MK, El-Sayed I, Xia P, Kaplan MJ, Eisele DW. Intensity modulated
radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol
Phys. 2007 Jan 1; 67(1):151-7.
Chen AM, Daly ME, Bucci MK, Xia P, Akazawa C, Quivey JM, Weinberg V, Garcia J, Lee NY,
Kaplan MJ, El-Sayad E, Eisele DW, Fu KK, Philips TL. Carcinomas of the paranasal sinuses and
nasal cavity treated with radiotherapy at a single institution over five decades: Are we making
improvement? Int J Radiat Oncol Biol Phys. 2007 Sept 1; 69(1):141-7.
Daly ME, Lievskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, Fee WF, Koong A, Goffinet DR,
Xing L, Le QT. Evaluation of patterns of failure and subjective salivary function in patients treated
with intensity-modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck
2007 Mar; 29(3):211-20.
© 2016 UC Regents